Skip to main content
. 2021 May 10;125(2):200–208. doi: 10.1038/s41416-021-01380-3

Fig. 1. Relative change in sum of longest diameters of tumour lesions from baseline to post-baseline nadir for RECIST-evaluable patients (n = 25, Phase 1b study).

Fig. 1

IHC immunohistochemistry.